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Abstract
Traditional Chinese medicine (TCM) has been applied to improve human health for millennia. In the TCM system,
“medicinal property” ( yao xing; hot and cold properties) is a core concept used to describe the inﬂuences of medicinal
materials on human physiological conditions, and metabolites are believed to be one of the major ingredients of TCMs
that affect their medicinal property. However, due to a lack of comprehensive analyses of TCM metabolomes, information about the relationships between TCM metabolite composition and medicinal property remains limited. In this
pilot study, a mass spectral molecular networking-based platform was established and applied to systematically proﬁle
the metabolome of 24 TCMs with various medicinal properties. The molecular networks were built based on the liquid
chromatography-tandem mass spectrometry (LC-MS/MS) data from 50% EtOH extracts of 24 TCMs. The results showed
that various classes of metabolites were clustered in the molecular networks, and the potential medicinal propertyassociated molecular families were ﬁltered by screening the medicinal property and the diversity of TCM sources. For
example, some speciﬁc types of ﬂavonoids were identiﬁed in the representative cold-property (han xing) molecular
families. In contrast, due to the limited sample size, the representative and universal hot-property (re xing) molecular
family has not been well revealed. In summary, this study provides methodology and information on the potential
relationships between the metabolite composition and the concept of medicinal property in TCM. Furthermore, the
results can serve as a foundation for mass spectral molecular networking-based analysis of TCM metabolomes, facilitating TCM research and development.
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1. Introduction

T

raditional Chinese medicine (TCM) has been
widely applied to prevent and treat various
human diseases for millennia. The development of
TCM is based on thousands of years of empirical
practice, and the principles and diverse usages of
TCM are recorded in detail in ancient Chinese
medicinal books, forming a unique therapeutic
system. Currently, TCM has become a mainstay of
health maintenance and promotion in several Asian
countries. In Taiwan, for example, TCM is included
in the National Health Insurance system and is
widely recognized and utilized by the locals.
In TCM theory, “medicinal property” ( yao xing;
also known as “medicinal nature”), is one of the core
concepts used to describe the functions of medicinal
materials, and the medicinal properties of different
TCM materials are recorded in various TCM books
such as Shen Nong's Classic of the Materia Medica
(shen nong ben cao jing; the earliest existing TCM
book). TCM materials can generally be categorized
into four medicinal properties, also known as the
“four qi” (si qi; cold, hot, warm, and cool) based on
their inﬂuences on human physiological conditions
and esthesia. TCM materials with “cold property”
(han xing) or “cool property” (liang xing) can alleviate
heat symptoms such as fever, thirst, swelling, and
sore throat [1]. For example, Scutellariae Radix
(huang qin; the root of Scutellaria baicalensis) is a
popular TCM with cold property, and it possesses
the functions of “clearing heat” (qing re) and
“detoxifying” ( jie du), which are effective in treating
inﬂammation and respiratory infections [2]. In
contrast, TCM materials with “hot property” (re xing)
or “warm property” (wen xing) can relieve cold
symptoms such as cold limbs, loss of appetite,
diarrhea, and vomiting [1]. For instance, a TCM with
hot property, Euodiae Fructus (wu zhu yu; the fruit of
Tetradium ruticarpum), is known for its functions of
“warming up interior” (wen zhong), “expelling cold”
(san han), “arresting vomiting” (zhi ou), and
“arresting diarrhea” (zhi xie) [3]. Clinically, the medicinal property is one of the fundamental concepts
that TCM practitioners use to prescribe appropriate
TCM formulas for treating different syndromes
(categorized patterns of symptoms and signs in a
patient at a speciﬁc stage of disease) [4].
Among the different ingredients, metabolites
appear to be one of the signiﬁcant components
determining the pharmacological effects of TCM,
implying that metabolite composition may affect the
medicinal property of TCM [5]. Previous studies
have investigated the chemical structure differences

403

in cold-property and hot-property TCMs using
computational approaches and principal component
analysis [6e8]; the compounds associated with cold
property generally possess a higher polarity and
more aliphatic rings or long chain alkenes [6,8],
while the compounds associated with hot property
typically have a lower average molecular weight and
more aromatic rings [6,7]. Although the general
comparative view of the chemical properties of
known compounds in the cold- and hot-property
TCMs has been proposed, understanding on the
relationships between TCM medicinal property and
metabolite composition is still limited. In addition,
TCM is often used in the form of crude extracts or
raw materials with limited processing, but conventional bioactivity-guided approaches for TCM
metabolite analysis provide little holistic information about the TCM metabolome proﬁle. Therefore,
the systematic identiﬁcation and characterization of
the metabolites in complex TCM mixtures remains a
signiﬁcant challenge in TCM research and development [9].
With advancements in analytical techniques,
especially high-resolution mass spectrometry and
computational methodology, signiﬁcant progress
has been made in metabolite analysis. Liquid
chromatography-mass spectrometry (LC-MS) is
currently the most versatile and commonly used
method for the metabolite proﬁling of TCM extracts
and biological matrices [10,11]. However, compound
identiﬁcation and structure elucidation for complex
mixtures remains a common challenge in MS data
analysis. The mass spectral molecular networking
(MN) approach has recently emerged and provided
a new perspective for metabolite discovery and
identiﬁcation in natural products research [12,13].
MN is a computational strategy for organizing tandem mass spectrometry (MS/MS) data; it allows the
visualization of the structural relationships among
molecules based on comparing their MS/MS spectral similarity so that the molecules with similar
fragmentation patterns (potential structural analogs)
are clustered to form molecular families [14]. Along
with mass spectral library matching and cuttingedge computational tools in network annotation,
MN has played an inﬂuential role in large-scale
compound identiﬁcation, structure prediction, and
chemical classiﬁcation [15].
The employment of the MN approach can enormously facilitate systematic metabolome analysis
and comparison of complex TCM samples with accurate MS/MS data. Furthermore, by integrating the
information about TCM material name and medicinal property into the molecular network, MN provides a practical way to decipher the metabolome
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differences between cold-property and hot-property
TCM. In this pilot study, 24 commonly-used TCMs
with various medicinal properties were extracted by
an automated extraction system and analyzed by
LC-MS/MS under standardized conditions; the potential relationships between TCM metabolite
composition and medicinal property were then
explored using the MN strategy.

2. Materials and methods
2.1. Materials
Twenty-four TCMs were selected based on their
medicinal properties and clinical applications. The
powders of 24 TCMs were provided by Sheng
Chang Pharmaceutical (Taoyuan, Taiwan), and
these TCM materials were authenticated by
morphology, microscopy, and chemical assays according to the Taiwan Herbal Pharmacopeia [16]. The
names, abbreviations, and medicinal properties of
the 24 selected TCMs are listed in Table 1.
2.2. TCM sample preparation
Accelerated Solvent Extractor (ASE 350) (Thermo
Scientiﬁc, Waltham, MA, USA) was used to prepare
the TCM extracts under standardized extraction
conditions. ASE is an automated system for extracting
organic compounds, and it uses elevated temperature and high pressure during the extraction process

to enhance extraction efﬁciency. Extraction was performed using 50% EtOH as extraction solvent. Brieﬂy,
5 g of TCM powder was added into a 66 mL stainless
steel extraction cell. After loading the cell into the
ASE system, the cell was automatically ﬁlled with
extraction solvent, pressurized (1500 psi), and heated
(50  C), with a static extraction time of 15 min. At the
end of each extraction procedure, the solvent rinse
volume and the nitrogen purge time were set at 100%
and 1 min, respectively. The resulting products obtained after the automated extraction were collected,
concentrated, and lyophilized to give 50% EtOH extracts of TCM.
2.3. Analysis of TCM metabolites by LC-MS/MS
LC-MS/MS was used to analyze the metabolites in
the 50% EtOH extracts of all selected TCMs. Brieﬂy,
dried extracts were re-dissolved in 50% EtOH at a
concentration of 10 mg/mL and analyzed using an
Agilent 1290 Inﬁnity II LC system coupled with a
6545XT AdvanceBio LC/Q-TOF (quadrupole timeof-ﬂight) mass spectrometer (Agilent Technologies,
Santa Clara, CA, USA). The chromatographic separation was carried out on an ACQUITY BEH C18
UPLC column (2.1  100 mm, 1.7 mm; Waters, Milford, MA, USA) with a 0.4 mL/min ﬂow rate and a
column temperature of 40  C. The mobile phase was
composed of water (A) and acetonitrile (B) (both
contained 0.1% formic acid). The gradient elution

Table 1. The 24 TCMs analyzed in this study.
English name

Chinese name

Abbreviation

Medicinal propertya

Oldenlandiae Diffusae Herba
Isatidis Radix
Scutellariae Barbatae Herba
Andrographis Herba
Rhei Radix et Rhizoma
Phellodendri Cortex
Scutellariae Radix
Coptidis Rhizoma
Lonicerae Japonicae Flos
Sophorae Flavescentis Radix
Toraxaci Herba
Gardeniae Fructus
Origani Vulgaris Herba
Chrysanthemi Flos
Forsythiae Fructus
Houttuyniae Herba
Zingiberis Rhizoma
Aconiti Lateralis Radix Praeparata
Cinnamomi Cortex
Processed Euodiae Fructus
Sinapis Albae Semen
Caryophylli Flos
Morindae Ofﬁcinalis Radix
Patriniae Herba

Bai hua she she cao
Ban lan gen
Ban zhi lian
Chuan xin lian
Da huang
Huang bo
Huang qin
Huang lian
Jin yin hua
Ku shen
Pu gong ying
Zhi zi
Bei yin chen
Ju hua
Lian qiao
Yu xing cao
Gan jiang
Pao fu zi
Rou gui
Zhi wu zhu yu
Bai jie zi
Ding xiang
Ba ji tian
Bai jiang cao

BHSSC
BLG
BZL
CXL
DH
HB
HQ
HL
JYH
KS
PGY
ZZ
BYC
JH
LQ
YXC
GJ
PFZ
RG
ZWZY
BJZ
DX
BJT
BJC

Cold
Cold
Cold
Cold
Cold
Cold
Cold
Cold
Cold
Cold
Cold
Cold
Mild cold
Mild cold
Mild cold
Mild cold
Hot
Hot
Hot
Hot
Warm
Warm
Mild warm
Neutral

a

The medicinal property of each TCM is classiﬁed according to the Taiwan Herbal Pharmacopeia [16].

conditions were set as follows: 0e1 min, 5% B;
1e16 min, 5e99.5% B; and 16e26 min, 99.5% B.
The column was re-equilibrated at 5% B for 3 min
between each run. The sample injection volume was
10 mL.
The Q-TOF mass spectrometer was equipped with
an electrospray ionization (ESI) source, and the analyses were performed separately in positive ion
mode and negative ion mode for each sample.
Source parameters were set as follows: capillary
voltage at 3000 V, nebulizer pressure at 35 psi,
sheath gas ﬂow rate at 12 L/min with a temperature
of 350  C, drying gas ﬂow rate at 9 L/min with a
temperature of 250  C, fragmentor voltage at 130 V,
skimmer voltage at 65 V, and nozzle voltage at 250 V
(in positive ion mode) or 1250 V (in negative ion
mode). Agilent MassHunter Workstation software
(version B.09.00) was used for LC-MS/MS data
acquisition. Data was collected in centroid mode
with the m/z range of 100e1500 and the scan rate of 5
spectra/s. To increase the coverage of compounds
targeted for MS/MS fragmentation, iterative datadependent acquisition (DDA) (ﬁve consecutive injections of the same sample) with active exclusion
was applied in MS/MS scans, and the top ﬁve
highest-intensity precursor ions per MS1 scan were
selected and fragmented with collision energy set at
40 V.
The LC-MS/MS data of the 50% EtOH extracts of
all selected TCMs are publicly available on the
MassIVE website (https://massive.ucsd.edu), and
the dataset accession numbers are summarized in
Table S1 (Supporting Information; https://www.
jfda-online.com/cgi/viewcontent.cgi?ﬁlename=1&
article=3425&context=journal&type=additional).
2.4. Molecular network construction
2.4.1. Data preprocessing
The LC-MS/MS data were converted from Agilent
MassHunter data format to mzML format using
MSConvert software (part of the ProteoWizard
package) [17], followed by performing a sequence of
data processing steps in MZmine software (version
2.53) [18]. Because the signal intensity in negative
ion data is generally weaker than in positive ion
data, some parameters were set at lower values for
negative ion data processing. The mass detection
was realized with the noise level set at 1000 (500 for
negative ion data) for MS1 and 100 (50 for negative
ion data) for MS2. The chromatogram building was
performed using the Automated Data Analysis
Pipeline (ADAP) chromatogram builder with a
minimum group size of scans of 5, a group intensity
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threshold of 1000 (500 for negative ion data), a
minimum highest intensity of 5000 (2500 for negative ion data), and an m/z tolerance of 0.006 m/z (or
25 ppm). The ADAP wavelets algorithm was used
for chromatographic deconvolution with the
following settings: S/N threshold ¼ 5, minimum
feature height ¼ 50000 (20000 for negative ion data),
coefﬁcient/area threshold ¼ 50, peak duration range
0.05e2 min (0.05e1 min for negative ion data), and
retention time (RT) wavelet range 0.03e0.15 min
(0.03e0.12 min for negative ion data). The MS/MS
scan pairing was carried out with an m/z range of
0.02 Da and an RT range of 0.1 min. The chromatograms were deisotoped using the isotopic
peaks grouper with an m/z tolerance of 0.006 m/z (or
25 ppm) and an RT tolerance of 0.1 min. Peak
alignment was performed using the join aligner
with an m/z tolerance of 0.006 m/z (or 25 ppm), an RT
tolerance of 0.3 min, a weight for m/z of 1, a weight
for RT of 1, and a minimum cos similarity of 0.5 for
MS2 spectral similarity comparison. The processed
results were exported as two ﬁles using the “Export/
Submit to GNPS-FBMN” built-in option: an .mgf ﬁle
containing MS/MS spectral information and a .csv
ﬁle containing a feature list with MS1 m/z, peak
retention time, and peak area information.
2.4.2. GNPS molecular networking
Global Natural Products Social Molecular
Networking (GNPS; https://gnps.ucsd.edu) was
used to generate molecular networks [19]. First, the
preprocessed LC-MS/MS data were uploaded to the
GNPS web-based platform, and a feature-based
molecular networking workﬂow (version 28.2) was
applied for molecular network building [20]. The
major parameter settings were set as follows: precursor ion mass tolerance of 0.02 Da, fragment ion
mass tolerance of 0.02 Da, minimum pair cosine
score of 0.7, and minimum matched fragment ions
of 6. After running the molecular networking algorithm on the GNPS server, the generated molecular
networks were downloaded from the job status
pages as Cytoscape data and then imported to
Cytoscape software (version 3.8.2) for molecular
network visualization and editing [21].
2.4.3. Compound identiﬁcation
Compound identiﬁcation was ﬁrst performed by
comparing the mass spectra against different mass
spectral libraries/sources, including (1) Traditional
Chinese Medicine Personal Compound Database
and Library (TCM PCDL; Agilent-NatureStandard)
[22]; (2) public spectral libraries on the GNPS website (such as MassBank and NIST) [19]; and (3) the
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mass spectra from the literature. Then, in silico tools,
including Network Annotation Propagation (NAP),
MS2LDA, and SIRIUS 4, were further used to predict
the structure or improve the structural annotation of
other unidentiﬁed compounds after spectral library
matching [23e25]. Finally, ClassyFire and MolNetEnhancer were applied for the structural classiﬁcation of identiﬁed compounds [26,27].

3. Results and discussion
3.1. Overview of the molecular networks of the 24
selected TCMs
The LC-MS/MS data from the 50% EtOH extracts of
24 TCMs were used for molecular network

construction. Because the positive and negative ion
data were independent data sets, their corresponding
molecular networks were constructed separately.
Fig. 1A shows the molecular network built with the
positive ion data from 50% EtOH extracts of 24 TCMs;
it contains 16269 nodes and 1265 molecular families.
The TCM source of each node (molecule) was visualized by assigning different colors to different TCMs,
and the TCMs with “cold” or “mild cold” (wei han)
medicinal property were labeled with cool colors such
as blue and green, while the TCMs with “hot”, “warm”
or “mild warm” (wei wen) medicinal property was
labeled with warm colors such as red and orange.
Based on the compound identiﬁcation results of
spectral library matching and in silico tool-aided

Fig. 1. Molecular networks of the 50% EtOH extracts of the 24 selected TCMs and the putative chemical classes of major molecular families. (A)
Positive ion data and (B) negative ion data. The number in the parentheses is the sequence number of the molecular family. The node size is proportional to the sum of the chromatographic peak area. The edge width is proportional to the MS/MS spectral similarity between two connected
molecules. The threshold of library match is cosine score 0.8.

structure prediction, the chemical classes of several
major molecular families were putatively classiﬁed as
ﬂavonoids, ﬂavonoid glycosides, phenolic acid derivatives, alkaloids, benzenoids, phenols, and so on
(Fig. 1A). The representative metabolites in these
classiﬁed molecular families are summarized in
Fig. S1A (Supporting Information; https://www.jfdaonline.com/cgi/viewcontent.cgi?ﬁlename=1&article=
3425&context=journal&type=additional). Of note, the
nodes in some of the major molecular families were
derived from various TCMs (such as the ﬂavonoidcontaining molecular family), whereas some of the
major molecular families were mainly derived from a
single TCM (such as the diarylheptanoid-containing
molecular family from gan jiang (GJ), and the neo-clerodane diterpenoid-containing molecular family from
ban zhi lian (BZL)).
On the other hand, the molecular network constructed with the negative ion data comprises 13219
nodes and 931 molecular families (Fig. 1B). Various
metabolites such as phenolic acid derivatives, ﬂavonoids, ﬂavonoid glycosides, and triterpenoids
were clustered as major molecular families, and
the corresponding representative metabolites are
illustrated in Fig. S1B (Supporting Information;
https://www.jfda-online.com/cgi/viewcontent.cgi?
ﬁlename=1&article=3425&context=journal&type=
additional). However, the molecules in some major
molecular families did not share particular structural features, and therefore these families were
roughly classiﬁed as glycosides or lipids and terpenoids. Most of the major molecular families were
derived from several TCMs, such as the molecular
families containing ﬂavonoid glycosides and the
molecular families containing phenolic acid derivatives. Nevertheless, the molecular family
composed of iridoid glycosides was derived from a
single TCM because these speciﬁc types of compounds were the characteristic metabolites of zhi zi
(ZZ).
These results demonstrated that the molecular
networking approach could reveal the metabolic
diversity of TCM metabolomes and visualize the
commonality and uniqueness of different classes of
metabolites among the 24 selected TCMs.
3.2. Representative molecular families of coldproperty and hot-property TCMs
To simplify the screening process for discovering
the representative molecular families associated
with medicinal properties, the TCMs with cold and
mild cold medicinal properties were categorized as
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cold-property TCMs, and the TCMs with hot, warm,
and mild warm medicinal properties were classiﬁed
as hot-property TCMs.
The representative cold-property TCM molecular
families were screened based on three criteria: (1)
the number of TCM sources (7 cold-property
TCMs and 2 hot-property TCMs); (2) the majority
of nodes in the molecular family being derived from
cold-property TCMs; and (3) containing identiﬁed
metabolites with a library match score 0.8 (a perfect match score is 1). Table 2 shows a summary of
representative cold-property TCM molecular families. After screening, six molecular families in the
molecular network built based on positive ion data
were representative cold-property TCM molecular
families. The molecules within these molecular
families were mainly derived from 13, 11, 11, 8, 7,
and 7 different cold-property TCMs, respectively.
On the other hand, for the molecular network built
from negative ion data, ﬁve molecular families, with
10, 8, 8, 8, and 7 cold-property TCMs, were ﬁltered to
be representative cold-property TCM molecular
families. The chemical classes of the TCM molecular
families associated with cold-property mostly
belonged to ﬂavonoids, ﬂavonoid glycosides, and
phenolic acid derivatives, out of which more ﬂavonoid compounds were clustered as large molecular
families in the positive ion data, and more phenolic
acid compounds were found in the negative ion data.
The screening criteria for hot-property TCM molecular families were similar to that of the coldproperty TCMs, but with a lower required number
of TCM sources (3 hot-property TCMs and 2
cold-property TCMs) as fewer hot-property TCMs
were included in the 24 selected TCMs. As a result,
four molecular families were found, and all were
discovered in the positive ion data (Table 3), with the
main sources being from 4, 3, 3, and 3 different hotproperty TCMs, respectively. The signiﬁcant cluster
of molecular families was classiﬁed as quinolones,
while the others were classiﬁed as sinapine derivatives, ﬂavonoids, and beta-carboline alkaloids.
3.3. Metabolites identiﬁed in the major
representative molecular families of cold-property
TCMs
Two major representative cold-property TCM
molecular families containing ﬂavonoids (with 13
cold-property TCM sources and 47 nodes; Fig. 2A)
and ﬂavonoid glycosides (with 11 cold-property
TCM sources and 79 nodes; Fig. 2B) were selected
for investigation. A list of identiﬁed compounds in
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Table 2. Summary of the representative cold-property TCM molecular families in the molecular networks of 50% EtOH extracts of the 24 selected
TCMs.
Chemical class and sequence
number of molecular family

Node
number

Number and name of TCM source categorized
according to medicinal propertya

Positive ion data
Flavonoids (17)

47

13 Cold (BHSSC, BYC, BZL, CXL, DH, HQ, JH, JYH, KS, LQ, PGY, YXC, ZZ)
2 Hot (DX, ZWZY)
1 Neutral (BJC)
11 Cold (BHSSC, BYC, BZL, CXL, HL, HQ, JH, JYH, KS, PGY, ZZ)
2 Hot (DX, ZWZY)
1 Neutral (BJC)
11 Cold (BHSSC, BZL, CXL, HB, HQ, JH, JYH, LQ, PGY, YXC, ZZ)
2 Hot (DX, ZWZY)
1 Neutral (BJC)
8 Cold (BYC, BZL, CXL, HL, HQ, JH, JYH, ZZ)
1 Hot (DX)
7 Cold (BYC, BZL, DH, HL, HQ, JYH, ZZ)
7 Cold (BHSSC, BLG, DH, HB, HQ, JYH, KS)
2 Hot (BJZ, PFZ)

Flavonoid glycosides (7)

79

Phenolic acids derivatives (44)b

26

Flavonoid glycosides (45)b

20

Flavonoids (46)b
Carbohydrates (47)b

31
6

Negative ion data
Phenolic acids derivatives (51)b

15

Stilbenes (52)b

9

Phenolic acids derivatives (53)b

25

Phenolic acids (54)b

3

Flavonoid glycosides (41)

31

a
b

10 Cold (BHSSC, BYC, CXL, HB, HL, JH, JYH, PGY, YXC, ZZ)
1 Hot (ZWZY)
1 Neutral (BJC)
8 Cold (BYC, BZL, CXL, DH, JH, JYH, KS, PGY)
1 Hot (ZWZY)
8 Cold (BYC, CXL, HB, JH, JYH, PGY, YXC, ZZ)
1 Hot (ZWZY)
1 Neutral (BJC)
8 Cold (BYC, BZL, DH, JH, JYH, LQ, PGY, YXC)
1 Hot (ZWZY)
1 Neutral (BJC)
7 Cold (BYC, BZL, CXL, DH, HQ, JH, KS)
1 Hot (ZWZY)

Cold medicinal property includes cold and mild cold; hot medicinal property includes hot, warm, and mild warm.
The molecular families are shown in Fig. S2 (Supporting Information).

the representative cold-property TCM molecular
families is presented in Table 4. Twelve ﬂavonoids,
including apigenin, baicalein, chrysin, luteolin, and
scutellarein, were identiﬁed, as shown in Fig. 2A;
ﬁfteen ﬂavonoid glycosides including apigetrin,

baicalin, and scutellarin were identiﬁed, as shown in
Fig. 2B. To further conﬁrm the identity of these
compounds, the identiﬁcation points were calculated according to the Commission Implementing
Regulation (EU) 2021/808 [28], which provides the

Table 3. Summary of the representative hot-property TCM molecular families in the molecular networks of 50% EtOH extracts of the 24 selected
TCMs.
Chemical class and sequence
number of molecular family

Node
number

Number and name of TCM source categorized
according to medicinal propertya

Positive ion data
Quinolones (8)

76

4
2
3
3
1
3
2

Sinapine derivatives (48)b
Flavonoids (49)c

5
11

Beta-carboline alkaloids (50)b

4

a

Hot (DX, PFZ, RG, ZWZY)
Cold (BLG, HB)
Hot (BJZ, GJ, ZWZY)
Hot (DX, GJ, ZWZY)
Cold (CXL)
Hot (BJT, GJ, ZWZY)
Cold (CXL, HL)

Cold medicinal property includes cold and mild cold; hot medicinal property includes hot, warm, and mild warm.
The molecular families are shown in Fig. 3B and Fig. S2 (Supporting Information; https://www.jfda-online.com/cgi/viewcontent.cgi?
ﬁlename=1&article=3425&context=journal&type=additional).
c
The molecular family is shown in Fig. S2 (Supporting Information; https://www.jfda-online.com/cgi/viewcontent.cgi?
ﬁlename=1&article=3425&context=journal&type=additional).
b
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Fig. 2. Representative cold-property TCM molecular families. (A) Flavonoids and (B) ﬂavonoid glycosides. The number in the parentheses is the
sequence number of the molecular family. Values in the nodes are precursor m/z. The node size is proportional to the sum of the chromatographic peak
area. The edge width is proportional to the MS/MS spectral similarity between two connected molecules. The threshold of library match is cosine score
0.8.

conﬁrmation and identiﬁcation strategy for MSbased analytical methods. Based on this EU regulation, verifying the identity of compounds requires

a minimum of four identiﬁcation points; for highresolution mass spectrometry such as Q-TOF, a
precursor ion (monitored in full scan) yields 1.5
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No.

RT (min)

Positive ion data
Flavonoids
1
2.84

2

Formula

Calculated
m/z

Observed
m/z

Error
(ppm)

Adduct

Identiﬁcation
pointa

Fragment ions (relative
abundance in %)b

TCM source

Ref.c

Epicatechin

C15H14O6

291.0863

291.0855

2.75

[MþH]þ

6.5

G; T

C15H10O7

303.0499

6.5

BHSSC, BJC, DX,
JYH, LQ, YXC,
ZWZY, ZZ

G; T

C15H10O6

287.0550

0.33
1.32
1.65
1.32
1.98
0.35
2.79
2.09
2.09

[MþH]þ

Luteolin
and isomers

303.0498
303.0495
303.0494
303.0495
303.0493
287.0549
287.0542
287.0544
287.0544

[MþH]þ

6.5

(21), 139.0381 (65),
(100), 119.0482 (18),
(11)
(46), 201.0538 (26),
(13), 173.0596 (13),
(13), 155.0488 (16),
(100), 137.0225 (50),
(14), 109.0282 (18)
(39), 241.0488 (8),
(5), 161.0229 (15),
(100), 139.0537 (5),
(12), 135.0434 (34),
(18), 107.0483 (6)
(21), 269.0436 (5),
(6), 169.0126 (20),
(5), 157.0640 (5),
(100), 121.0278 (14),
(41)
(25), 151.0381 (6),
(7), 139.0380 (60),
(5), 123.0436 (100)
(31), 163.0385 (5),
(100), 145.0278 (16),
(5), 121.0279 (18),
(44)

DH

Quercetin
and isomers

147.0431
123.0436
111.0433
229.0489
183.0431
165.0177
153.0178
121.0273
287.0540
213.0538
153.0176
137.0224
117.0326
287.0544
195.0437
167.0486
123.0074
119.0489
153.0170
147.0426
125.0225
271.0598
153.0182
141.0693
119.0491

BHSSC, BYC, BZL,
CXL, DH, DX, HQ,
JH, JYH, PGY

G; T

BZL, HQ

T

DH

G; T

BYC, BZL, CXL,
JH, KS

G; T

287.0541
165.0166
153.0164
137.0207
107.0463
303.0483
229.0487
177.0165
153.0165
133.0264
271.0595
151.0538
123.0079
103.0542
163.0387
145.0270
123.0434

(16), 213.0531 (21),
(17), 157.0630 (18),
(100), 147.0423 (11),
(16), 121.0257 (59),
(17), 105.0310 (12)
(51), 257.0432 (13),
(18), 203.0327 (47),
(8), 155.0473 (6),
(100), 151.0363 (27),
(18), 105.0309 (15)
(14), 169.0127 (10),
(5), 141.0693 (5),
(100), 105.0331 (8),
(23)
(5), 153.0179 (100),
(7), 135.0433 (18),
(6), 117.0327 (24)

BHSSC, BJC, DX

G; T

DX

G

BZL, HQ, ZZ

T

BZL, HQ, JH

G; T

4

4.28
4.52
5.32

Scutellarein
and isomers

C15H10O6

287.0550

287.0549
287.0551
287.0549

0.35
0.35
0.35

[MþH]þ

6.5

5

4.34

Epicatechin
gallate

C22H18O10

443.0973

443.0954

4.29

[MþH]þ

6.5

6

4.38
4.80
5.29
5.66
6.48
6.52
4.67
6.66

Apigenin
and isomers

C15H10O5

271.0601

6.5

C15H10O6

287.0550

2.21
1.48
1.48
1.11
1.48
0.74
1.39
2.09

[MþH]þ

Kaempferol
and isomers

271.0595
271.0597
271.0597
271.0598
271.0605
271.0603
287.0546
287.0544

[MþH]þ

6.5

8

5.09

Tricetin

C15H10O7

303.0499

303.0490

2.97

[MþH]þ

6.5

9

5.49
6.00
7.16
7.18
5.69

Baicalein
and isomers

C15H10O5

271.0601

6.5

C15H12O6

289.0707

0.37
0.37
33.94
0.74
0.35

[MþH]þ

Eriodictyol

271.0600
271.0600
271.0693
271.0599
289.0706

[MþH]þ

6.5

7

10
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3.63
4.00
4.28
4.66
5.82
3.83
4.28
5.84
6.26

Name
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Table 4. Summary of the identiﬁed metabolites in the major representative cold-property TCM molecular families.

5.92
6.10
8.37

Chrysin
and isomers

C15H10O4

255.0652

255.0649
255.0648
255.0649

1.18
1.57
1.18

[MþH]þ

6.5

12

6.76

Hesperetin

C16H14O6

303.0863

303.0861

0.66

[MþH]þ

6.5

C27H30O17

627.1556

627.1562

0.96

[MþH]þ

4

C21H20O11

449.1078

4

479.0820

0.22
0.22
0.45
1.25

[MþH]þ

C21H18O13

449.1079
449.1079
449.1076
479.0814

[MþH]þ

4

Quercetin-3-Oxylosylglucoside
Kaempferol-3-Ogentiobioside
Luteolin-7-Orutinoside
Scutellarin and
isomers

C26H28O16

597.1450

597.1447

0.50

[MþH]þ

4

C27H30O16

611.1607

611.1602

0.82

[MþH]þ

4

C27H30O15

595.1658

595.1650

1.34

[MþH]þ

4

C21H18O12

463.0871

4

C21H18O11

447.0922

[MþH]þ

4

Apigetrin and
isomers
Leucoside
Rhoifolin
Apigenin-7-Oglucuronide
Oroxin A and
isomers

C21H20O10

433.1129

[MþH]þ

4

C26H28O15
C27H30O14
C21H18O11

581.1501
579.1708
447.0922

0.22
0.65
1.30
0.00
0.22
0.45
1.34
0.23
0.23
1.72
0.17
0.89

[MþH]þ

Baicalin and
isomers

463.0870
463.0874
463.0865
447.0922
447.0923
447.0924
447.0916
433.1130
433.1128
581.1491
579.1709
447.0918

[MþH]þ
[MþH]þ
[MþH]þ

4
4
4

C21H20O10

433.1129

4

593.1865
431.0973

0.69
0.69
0.46
0.51
0.70

[MþH]þ

C28H32O14
C21H18O10

433.1126
433.1126
433.1127
593.1862
431.0970

[MþH]þ
[MþH]þ

4
4

Flavonoid glycosides
13
3.63
Quercetin-3-Osophoroside
14
3.68
Kaempferol-7-O3.92
glucoside
4.38
and isomers
15
3.79
Quercetin-3-Oglucuronide
16

3.89

17

3.91

18

4.22

19

4.27
4.62
5.31
4.29
5.48
6.27
8.27
4.41
4.80
4.57
4.68
4.85

20

21
22
23
24
25

26
27

5.53
6.00
6.31
5.86
6.10

Buddleoside
Chrysin-7-Oglucuronide

255.0652
153.0184
147.0437
129.0335
103.0545
177.0537
149.0594
134.0353

(40), 153.0697 (12),
(100), 152.0619 (18),
(9), 139.0540 (5),
(26), 105.0333 (21),
(60)
(8), 153.0182 (100),
(15), 145.0269 (9),
(8), 117.0326 (26)

BZL, HQ

G; T

JH

T

303.0506
127.0380
287.0557
169.0127
119.0487
303.0502
169.0124
123.0073
303.0505
115.0379
287.0522
127.0380
287.0550

(100), 145.0487 (1),
(2), 109.0278 (1)
(100), 269.0440 (2),
(1), 123.0072 (2),
(2)
(100), 285.0389 (1),
(1), 135.0435 (1),
(1)
(100), 127.0381 (1),
(1)
(100), 145.0483 (1),
(1)
(100)

BHSSC

T

BJC, BYC, BZL,
JH, JYH, PGY

T

BYC, BZL, HQ

G

BHSSC, JYH, ZWZY

G

BHSSC, BYC, PGY

G; T

CXL, JYH, PGY, ZWZY

G

287.0554
169.0125
119.0487
271.0612
169.0128
103.0541

(100), 269.0435 (1),
(1), 123.0073 (1),
(1)
(100), 253.0492 (2),
(1), 123.0077 (2),
(1)

BYC, BZL, CXL,
DX, HQ, JH

T

HQ, ZZ

G; T

271.0604
119.0487
287.0540
271.0599
271.0594
119.0482
271.0602
169.0129
103.0541
285.0765
255.0652

(100), 153.0181 (4),
(1)
(100), 153.0167 (1)
(100)
(100), 153.0169 (2),
(1)
(100), 253.0489 (2),
(1), 123.0077 (3),
(1)
(100), 242.0568 (1)
(100), 153.0181 (2)

BZL, JH, JYH, KS

G; T

BYC
CXL, JH, JYH, ZWZY
BYC, BZL, CXL

G
G; T
G

HQ

T

BYC, HL, JH, PGY
HQ

G; T
G
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RT: Retention time.
a
The identiﬁcation points were calculated according to the Commission Implementing Regulation (EU) 2021/808 [28]; the identiﬁcation points of a precursor ion (monitored in full
scan) and a product ion in high-resolution mass spectrometry are 1.5 and 2.5, respectively. The mass spectrum with the highest library match score was selected for identiﬁcation point
calculation if more than one molecule was identiﬁed as the same metabolite (potential structural isomer).
b
The mass spectrum with the highest library match score was selected to represent the fragment ions if more than one molecule was identiﬁed as the same metabolite (potential
structural isomer). The fragment ions that are underlined were the characteristic product ions used for identiﬁcation point calculation. The characteristic product ions were selected
based on the information of characteristic product ions of ﬂavonoids in the literature [42,43].
c
G: Public spectral libraries on the GNPS website; T: TCM PCDL.
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Fig. 3. Representative hot-property TCM molecular families. (A) Quinolone alkaloids and (B) other alkaloids. The number in the parentheses is the
sequence number of the molecular family. Values in the nodes are precursor m/z. The node size is proportional to the sum of the chromatographic peak
area. The edge width is proportional to the MS/MS spectral similarity between two connected molecules. The threshold of library match is cosine score
0.8.

points, and a characteristic product ion yields 2.5
points. Therefore, the obtained identiﬁcation points
of the ﬂavonoids and ﬂavonoid glycosides were 6.5
(one precursor ion and two characteristic product
ions) and 4 (one precursor ion and one characteristic
product ion), respectively, suggesting that their
identity was successfully conﬁrmed.
Based on spectral library matching, several nodes
with different retention times were annotated to be
the same compound, indicating that there were
structural isomers of some types of ﬂavonoids with
similar MS/MS fragmentation patterns. For
example, the luteolin-type group (luteolin and

isomers in Fig. 2A) consisted of four nodes with the
retention time of 3.83, 4.28, 5.84, and 6.26 min; this
suggested that there were three structural isomers
of luteolin in the luteolin-type group. However,
further analysis will be needed to conﬁrm the exact
node of luteolin by comparing the retention time
with the standard compound.
Although there may be a few structural isomers in
the representative cold-property TCM molecular
families, the general structural features of the
potentially cold property-related metabolites were
revealed using the molecular networking strategy.
For example, luteolin- and apigenin-type ﬂavonoids

were grouped in the representative cold-property
TCM molecular family (Fig. 2A). They were predominantly derived from nine and ﬁve cold-property TCMs, respectively; this indicates that these
speciﬁc types of ﬂavonoids may be part of the
consensus metabolites in cold-property TCM. Of
note, baicalein-, chrysin-, and scutellarein-type ﬂavonoids were mainly derived from only one or two
cold-property TCMs. Still, they were clustered in
the sub-family (Fig. 2A, upper right) with the majority of nodes from various cold-property TCM
sources, suggesting that the structural features of
these ﬂavonoids may also be involved in the coldproperty TCM-related metabolites. On the other
hand, although kaempferol- and quercetin-type
ﬂavonoids were found in the cold-property TCM
molecular family, most were derived from both
cold- and hot-property TCMs; therefore, they may
not serve as the consensus metabolites of coldproperty TCMs.
Several corresponding glycosides of the ﬂavonoids in Fig. 2A were identiﬁed in another coldproperty TCM molecular family (Fig. 2B), including
apigetrin-type ﬂavonoid glycosides (apigenin-7-Oglucoside and isomers), apigenin-7-O-glucuronide,
rhoifolin (apigenin-7-O-rutinoside), buddleoside (40 methoxyapigenin-7-O-rutinoside),
baicalin-type
ﬂavonoid glycosides (baicalein-7-O-glucuronide
and isomers), oroxin A-type ﬂavonoid glycosides
(baicalein-7-O-glucoside and isomers), scutellarintype ﬂavonoid glycosides (scutellarein-7-O-glucuronide and isomers), chrysin-7-O-glucuronide, and
luteolin-7-O-rutinoside. In addition, kaempferoland quercetin-type ﬂavonoid glycosides such as
kaempferol-7-O-glucoside
and
quercetin-3-Oglucuronide were also present in this molecular
family and mainly derived from cold-property
TCMs, which is different from their aglycones that
were derived from both cold- and hot-property
TCMs; this observation implies that there may be
differences in the glycosylation of these ﬂavonoids
between the selected cold- and hot-property TCMs.
Some speciﬁc types of ﬂavonoids (apigenin, baicalein, chrysin, luteolin, and scutellarein) and their
corresponding glycosides are mutually present in
the representative cold-property molecular families,
conﬁrming their potential roles as part of the
consensus metabolites in cold-property TCMs. The
general structural features of the cold-property
TCM-related ﬂavonoids are proposeddﬂavones
with two or three hydroxyl groups on ring A (at
positions 5 and 7, or 5, 6, and 7) and zero, one, or two
hydroxyl groups on ring B (at position 40 , or 30 and
40 ). At the same time, the predominant sugar moiety
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of their glycosides was glucose or glucuronic acid
attached at the C-7 position on ring A. Compared to
the chemical properties of cold property-associated
compounds (found to have a higher polarity and
more aliphatic rings) reported in the previous study
[6], the speciﬁc types of ﬂavonoids in the representative cold-property molecular families in this study
may concur with respect to the property of higher
polarity but not with respect to having more
aliphatic rings. The difference is probably because
numerous types of common metabolites were not
included in the chemical property analysis in the
previous study [6] (because a compound ﬁltering
process was performed before conducting the
analysis), and the obtained chemical properties
were general features that may not universally ﬁt all
speciﬁc classes of compounds.
Furthermore, the cold property-associated ﬂavonoids investigated in this study (including apigenin,
baicalein, chrysin, luteolin, scutellarein, and so on)
have mostly been reported to possess various bioactivities, notably, anti-inﬂammation and antioxidation [29e34], which further connects their potential pharmacological roles to the roles ascribed to
the cold property of TCM such as “clearing heat”
(qing re).
3.4. Metabolites identiﬁed in the major
representative molecular families of hot-property
TCMs
Most representative molecular families of hotproperty TCMs were mainly composed of molecules
from single hot-property TCM, probably because
fewer hot-property TCMs in the samples were
investigated. Therefore, based on the family size
and the diversity of hot-property TCMs, the prominent molecular family containing 76 nodes with
four hot-property TCM sources was selected for
further study (Fig. 3A). Quinolone alkaloids with
different side chains were identiﬁed in this molecular family (Table S2; Supporting Information;
https://www.jfda-online.com/cgi/viewcontent.cgi?
ﬁlename=1&article=3425&context=journal&type=
additional), and several quinolone alkaloids were
found to have potential structural isomers, which is
probably due to the variety in the structure of side
chains, such as the position of the double bond. In
addition, it was notable that most nodes were predominantly derived from zhi wu zhu yu (ZWZY).
This is reasonable because quinolone alkaloids are
one of the major characteristic metabolites of
ZWZY. However, the library-based compound
identiﬁcation rate of this molecular family was
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relatively low. Therefore, manual identiﬁcation was
performed to identify other known quinolone alkaloids of ZWZY by comparing the exact mass and
MS/MS fragmentation patterns with those in the
literature [35,36].
The sub-family in the middle part of the representative hot-property TCM molecular family was
mainly derived from four different hot-property
TCMs, suggesting that the compounds in this subfamily may be metabolites present in all four hotproperty TCMs. Four types of quinolone alkaloids
with different side chain structural features were
identiﬁed in this sub-family. Their side chains
comprised 11 carbons with one double bond, 12
carbons with one double bond, 13 carbons with two
double bonds, and 15 carbons with three double
bonds, respectively; the known quinolone alkaloids
of ZWZY are shown as the example structure in
each isomer group. Previous studies have reported
that the quinolone alkaloids from ZWZY possess
antibacterial and cytotoxic activities [36,37]. However, these bioactivities have no undeniable
connection to the hot property of TCM.
Two smaller molecular families identiﬁed in three
hot-property TCMs are shown in Fig. 3B. Sinapine
and its potential isomers were identiﬁed in one of
the molecular families, while two beta-carboline
alkaloids (harman and norharman) were identiﬁed
in the other molecular family (Table S2; Supporting
Information;
https://www.jfda-online.com/cgi/
viewcontent.cgi?ﬁlename=1&article=3425&context=
journal&type=additional). Sinapine is a major characteristic metabolite of bai jie zi (BJZ) with antioxidant
and acetylcholinesterase inhibitory activities [38,39].
Harman and norharman have been reported to
possess antimicrobial and monoamine oxidase
inhibitory activities [40,41]. Nevertheless, there
seems to be no direct association between these
bioactivities and the medicinal properties of hotproperty TCM. Further study using more hot-property TCM will be needed to discover more hot
property-associated metabolites.

4. Conclusions
This pilot study successfully developed a mass
spectral molecular networking-based platform for
TCM metabolite analysis. This platform was utilized
as a visualization approach to reveal and explore the
metabolic diversity of the TCM metabolomes. In
contrast to previous studies that applied in silico
analysis to provide the comparative chemical
properties of known metabolites in cold- and hotproperty TCMs, the speciﬁc chemical classes of
metabolites were characterized in the present study.

By screening the medicinal property and the diversity of TCM sources of each molecular family, the
potentially cold property-associated metabolites
were predominantly ﬂavonoids, ﬂavonoid glycosides, and phenolic acid derivatives. It was further
revealed that luteolin and apigenin could be the
characteristic ﬂavonoids of cold-property TCMs.
Therefore, further investigating the roles of these
types of ﬂavonoids in the cold property of TCM
would be worthwhile.
On the other hand, we could not reveal universal
hot property-associated metabolites in this pilot
study because the sample size of hot-property
TCMs is small. Some alkaloids, such as quinolones,
were identiﬁed in hot-property TCMs. However, the
alkaloid structures are highly diverse and are found
in cold- and hot-property TCMs. For example, leonurine and berberine were isolated from coldproperty TCMs Leonurus artemisia and Coptis chinensis, respectively. In contrast, ephedrine and
corydalis B were isolated from Chinese Ephedra
Herb (Ma Huang) and Corydalis Rhizoma, respectively, and both of them are hot-property TCMs.
Therefore, a comprehensive and detailed structural
classiﬁcation for alkaloids from more TCMs would
be needed to investigate further or conﬁrm the relationships between alkaloids and the medicinal
properties of TCMs.
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